← Leaderboards
Johnny J He
Indiana Univ-Purdue Univ At Indianapolis
$17,169,604
Attributed
$17,434,184
Total exposure
14
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,434,184 · 14
By mechanism
R01$14,797,013 · 7
R21$1,298,929 · 4
U54$1,097,271 · 1
R25$200,971 · 1
R13$40,000 · 1
Top collaborators
- David W Crabb2 shared
- Nicholas Joseph Grahame2 shared
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainAstrocytesInfectionMolecularPreventHiv-1CellsHiv InfectionsLifeNeuropathologyBrain DiseasesCaringAffectPathogenesisAcquired Immunodeficiency SyndromeGene ExpressionMediatingNeuronsMacrophageEconomic ImpactIntegration Host FactorsViralNeurotoxicityIn Vivo
Grant awards (54)
Positive allosteric modulator PNU-120596 to treat HIV-associated neurocognitive disorders$678,398
R01 · FY2025 · DA · contact PI
Positive allosteric modulator PNU-120596 to treat HIV-associated neurocognitive disorders$678,398
R01 · FY2024 · DA · contact PI
Investigator Development Core$219,100
U54 · FY2021 · MD · contact PI
HIV Infection and Latency In Astrocytes$575,693
R01 · FY2020 · DA · contact PI
Investigator Development Core$222,575
U54 · FY2020 · MD · contact PI
HIV Infection and Latency In Astrocytes$575,693
R01 · FY2019 · DA · contact PI
miR-132 a new player in HIV/neuroAIDS$532,001
R01 · FY2019 · NS · contact PI
Investigator Development Core$221,474
U54 · FY2019 · MD · contact PI
HIV Infection and Latency In Astrocytes$538,790
R01 · FY2018 · DA · contact PI
miR-132, a new player in HIV/neuroAIDS$532,001
R01 · FY2018 · NS · contact PI
Investigator Development Core$221,635
U54 · FY2018 · MD · contact PI
UNT Health Science Center IMSD$200,971
R25 · FY2018 · GM · contact PI
HIV Infection and Latency In Astrocytes$538,790
R01 · FY2017 · DA · contact PI
miR-132, a new player in HIV/neuroAIDS$532,001
R01 · FY2017 · NS · contact PI
Investigator Development Core$212,487
U54 · FY2017 · MD · contact PI
HIV Infection and Latency In Astrocytes$538,060
R01 · FY2016 · DA · contact PI
miR-132, a new player in HIV/neuroAIDS$532,001
R01 · FY2016 · NS · contact PI
miR-132, a new player in HIV/neuroAIDS$531,271
R01 · FY2015 · NS · contact PI
GFAP as a novel HIV/neuroAIDS biomarker$475,594
R01 · FY2014 · MH · contact PI
GFAP as a novel HIV/neuroAIDS biomarker$460,432
R01 · FY2013 · MH · contact PI
Sam68 and HIV-1 replication control in astrocytes$333,507
R01 · FY2013 · NS · contact PI
GFAP as a novel HIV/neuroAIDS biomarker$440,687
R01 · FY2012 · MH · contact PI
Sam68 and HIV-1 replication control in astrocytes$345,603
R01 · FY2012 · NS · contact PI
GFAP as a novel HIV/neuroAIDS biomarker$447,175
R01 · FY2011 · MH · contact PI
Sam68 and HIV-1 replication control in astrocytes$196,306
R01 · FY2011 · NS · contact PI
Sam68 and HIV-1 replication control in astrocytes$169,418
R01 · FY2011 · NS · contact PI
HIV interaction with drugs of abuse and adult neurogenesis$135,575
R21 · FY2011 · DA · contact PI
GFAP as a novel HIV/neuroAIDS biomarker$69,063
R01 · FY2011 · MH · contact PI
HIV interaction with drugs of abuse and adult neurogenesis$42,735
R21 · FY2011 · DA · contact PI
Sam68 and HIV-1 replication control in astrocytes$10,965
R01 · FY2011 · NS · contact PI
GFAP as a novel HIV/neuroAIDS biomarker$549,636
R01 · FY2010 · MH · contact PI
Sam68 and HIV-1 replication control in astrocytes$369,456
R01 · FY2010 · NS · contact PI
HIV interaction with drugs of abuse and adult neurogenesis$192,500
R21 · FY2010 · DA · contact PI
Sam68 and HIV-1 replication control in astrocytes$373,188
R01 · FY2009 · NS · contact PI
Mechanisms of HIV-1 Entry and Pathogenesis in Astrocytes$298,970
R01 · FY2008 · NS · contact PI
Alcohol abuse in a small rodent neuroAIDS model$217,063
R21 · FY2008 · AA · contact PI
Drug Abuse and NeuroAIDS in China$140,484
R21 · FY2008 · DA · contact PI
Sino-US Symposium in Drug Abuse, HIV and HCV Comorbidity$25,000
R13 · FY2008 · DA · contact PI
Sino-US Symposium in Drug Abuse, HIV and HCV Comorbidity$15,000
R13 · FY2008 · DA · contact PI
Mechanisms of HIV-1 Entry and Pathogenesis in Astrocytes$298,970
R01 · FY2007 · NS · contact PI
Use a novel Tat transgenic model to develop neuroAIDS therapeutics$211,113
R21 · FY2007 · DA · contact PI
Alcohol abuse in a small rodent neuroAIDS model$179,807
R21 · FY2007 · AA · contact PI
Mechanisms of HIV-1 Entry and Pathogenesis in Astrocytes$307,900
R01 · FY2006 · NS · contact PI
Tat Interaction with LRP and Its Role in AIDS Dementia$286,088
R01 · FY2006 · MH · contact PI
Use a novel Tat transgenic model to develop neuroAIDS therapeutics$179,652
R21 · FY2006 · DA · contact PI
Mechanisms of HIV-1 Entry and Pathogenesis in Astrocytes$315,309
R01 · FY2005 · NS
Tat Interaction with LRP and Its Role in AIDS Dementia$292,973
R01 · FY2005 · MH
Tat Interaction with LRP and Its Role in AIDS Dementia$292,973
R01 · FY2004 · MH
Tat Interaction with LRP and Its Role in AIDS Dementia$292,973
R01 · FY2003 · MH
MECHANISMS OF HIV-1 ENTRY AND PATHOGENESIS IN ASTROCYTES$260,750
R01 · FY2003 · NS
Tat Interaction with LRP and Its Role in AIDS Dementia$292,973
R01 · FY2002 · MH
MECHANISMS OF HIV-1 ENTRY AND PATHOGENESIS IN ASTROCYTES$260,750
R01 · FY2002 · NS
MECHANISMS OF HIV-1 ENTRY AND PATHOGENESIS IN ASTROCYTES$260,750
R01 · FY2001 · NS
MECHANISMS OF HIV-1 ENTRY AND PATHOGENESIS IN ASTROCYTES$311,507
R01 · FY2000 · NS